Processa Pharmaceuticals Inc
PCSA
$1.77-6.84%
End of day · as of Oct 14, 2026, 2:00 AM ET
Mkt cap
$5.91M
EV/Sales
N/A
P/E ratio
N/A
FY2022 Revenue
N/A
EPS (H1 2026)
$-2.47
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported PCSA revenue for 2022-12-31 was $0. Net income was -$27.4M. PCSA currently screens at market cap $5.9M.
Use this PCSA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PCSA income, balance, and cash tables.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company in the Healthcare sector.
Latest cached Processa Pharmaceuticals Inc (PCSA) net income for Dec 31, 2022 was -$27.4M. Statements: https://lician.com/financials/pcsa
Processa Pharmaceuticals Inc (PCSA) market capitalization is $5.9M on the latest cached snapshot.
Processa Pharmaceuticals Inc (PCSA) cached previous close $1.90; day range $1.77 – $1.93; volume 63,654. Session quote: https://lician.com/quote/pcsa
Processa Pharmaceuticals Inc (PCSA) latest cached earnings event is "PCSA earnings" on Aug 20, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PCSA filing is 8-K/A · Oct 5, 2026. Filings: https://lician.com/sec/pcsa